CJC-1295 (no DAC) and GHRP-2 is a research peptide blend developed to examine synergistic stimulation of the growth hormone axis through dual receptor pathways. CJC-1295 (Mod GRF 1–29) activates the GHRH receptor, initiating cAMP/PKA signaling and GH synthesis, while GHRP-2 binds to the ghrelin receptor (GHS-R1a), triggering Gq/11-mediated calcium influx. This blend is utilized in preclinical studies investigating hypothalamic–pituitary coordination, peptide receptor interaction, and pulsatile hormone release mechanisms.
For research use only. Not for human consumption.
References:
Bowers CY et al., Endocrinology, 1990 126(2):1165–1171
Teichman SL et al., J Clin Endocrinol Metab, 2006 91(2):479–487
Kojima M et al., Nature, 1999 402(6762):656–660
New
CJC-1295 (no DAC), GHRP-2 10mg (Blend)
$95.00
CJC-1295 (no DAC) and GHRP-2 is a research peptide blend developed to examine synergistic stimulation of the growth hormone axis through dual receptor pathways. CJC-1295 (Mod GRF 1–29) activates the GHRH receptor, initiating cAMP/PKA signaling and GH synthesis, while GHRP-2 binds to the ghrelin receptor (GHS-R1a), triggering Gq/11-mediated calcium influx. This blend is utilized in preclinical studies investigating hypothalamic–pituitary coordination, peptide receptor interaction, and pulsatile hormone release mechanisms.
Description
Shipping & Delivery
Related products
BPC 157 500mcg (60 Capsules)
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
BPC-157, TB-500 (Blend)
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
BPC-157, TB-500, KPV, GHK-Cu 80mg (Klow Blend)
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
TB-500 (Thymosin Beta-4) (43aa) (2mg x 10 Vials = 20mg)
TB-500 (Thymosin Beta-4) is a 43 amino acid peptide sequence. In animal models, Thymosin Beta-4 has been shown to improve blood vessel growth, regulate wound healing, decrease inflammation, and reduce oxidative damage in the heart and central nervous system. Thymosin-beta-4 has a role in protection, tissue repair, regeneration and remodeling of injured or damaged tissues. It is also of active interest in anti-aging research.
Reviews
There are no reviews yet.